Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Mesothelioma, Malignant × lenvatinib × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Hepatocellular 33 Cholangiocarcinoma 11 Carcinoma, Renal Cell 7 Stomach Neoplasms 5 Neoplasms 4 Liver Neoplasms 4 Uterine Cervical Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Biliary Tract Neoplasms 3 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Small Cell Lung Carcinoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Kidney Neoplasms 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Breast Neoplasms 2 Advanced Solid Tumor 2 Vulvar Neoplasms 1 Urogenital Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Solid Tumor, Adult 1 Solid Tumor 1 Sarcoma 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Diseases 1 Neuroendocrine Tumors 1

Interventions

Pemetrexed 4 Cisplatin 4 pembrolizumab 3 Nivolumab 3 Carboplatin 3 Ipilimumab 2 olaparib 1 lenvatinib 1 enzalutamide 1 atezolizumab 1 Thoracoscopy 1 Thoracic Surgery, Video-Assisted 1 Surgery, Computer-Assisted 1 Paclitaxel 1 Interleukin-2 1 Injections 1 Indocyanine Green 1 In Situ Hybridization, Fluorescence 1 Combined Modality Therapy 1 Cerebral Decortication 1 Brentuximab Vedotin 1 Blood Component Removal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06318286 2025-05-25

PENINSULA

Hyogo Medical University

Phase 2 Recruiting

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡